The Immune Synapse as a Novel Target for Therapy
The immune synapse can be compared to a molecular machine that controls T cell activation when getting in contact with an antigen-presenting cell (APC). The immune synapse is involved in the transfer of information across the T cell–APC junction. It plays an essential role in the control and nature...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Basel :
Birkhäuser Basel,
2008.
|
| Series: | Progress in Inflammation Research
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- The immune synapse and T cell activation: regulation by chemokines
- The induction of regulatory T cells by targeting the immune synapse
- Infiltrating the immunological synapse: prospects for the use of altered peptide ligands for the treatment of immune pathology
- Targeting CD4 for the induction of dominant tolerance
- Anti-CD3: from T cell depletion to tolerance induction
- Immune modulation by CD40L blockade
- CTLA-4-immunoglobulin and indoleamine 2,3-dioxygenase in dominant tolerance
- Adhesion molecules as therapeutic targets
- E3 ubiquitin ligases and immune tolerance: Targeting the immune synapse from within?
- FOXP3 biochemistry will lead to novel drug approaches for vaccines and diseases that lack suppressor T cells
- Transforming growth factor-?: From its effect in T cell activation to a role in dominant tolerance
- From mice to men: the challenges of developing tolerance-inducing biological drugs for the clinic.